Latest period
$2.51B
YoY change
+1.1%
5Y CAGR
+0.8%
Peak year (2025)
$24.53B
Latest annual
$24.53B
Operating Cash Flow history chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: $24.53B
Operating Cash Flow growth chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: +1.1%
Operating Cash Flow history table for Johnson & Johnson (JNJ) from 1989 to 2025
| 2025 | $24.53B | +1.1% | +$264.00M | ||
| 2024 | $24.27B | +6.5% | +$1.48B | ||
| 2023 | $22.79B | +7.5% | +$1.60B | ||
| 2022 | $21.19B | -9.5% | −$2.22B | ||
| 2021 | $23.41B | -0.5% | −$126.00M | ||
| 2020 | $23.54B | +0.5% | +$120.00M | ||
| 2019 | $23.42B | +5.5% | +$1.22B | ||
| 2018 | $22.20B | +5.4% | +$1.15B | ||
| 2017 | $21.06B | +12.2% | +$2.29B | ||
| 2016 | $18.77B | -2.7% | −$512.00M | ||
| 2015 | $19.28B | +4.4% | +$808.00M | ||
| 2014 | $18.47B | +6.1% | +$1.06B | ||
| 2013 | $17.41B | +13.1% | +$2.02B | ||
| 2012 | $15.40B | +7.7% | +$1.10B | ||
| 2011 | $14.30B | -12.7% | −$2.09B | ||
| 2010 | $16.39B | -1.1% | −$186.00M | ||
| 2009 | $16.57B | +10.7% | +$1.60B | ||
| 2008 | $14.97B | -1.8% | −$277.00M | ||
| 2007 | $15.25B | +7.0% | +$1.00B | ||
| 2006 | $14.25B | +20.0% | +$2.37B | ||
| 2005 | $11.88B | +6.7% | +$746.00M | ||
| 2004 | $11.13B | +5.1% | +$536.00M | ||
| 2003 | $10.60B | +29.6% | +$2.42B | ||
| 2002 | $8.18B | -7.8% | −$688.00M | ||
| 2001 | $8.86B | +35.1% | +$2.30B | ||
| 2000 | $6.56B | +15.6% | +$886.00M | ||
| 1999 | $5.68B | +16.2% | +$791.00M | ||
| 1998 | $4.89B | +12.5% | +$543.00M | ||
| 1997 | $4.34B | +11.6% | +$452.00M | ||
| 1996 | $3.89B | +15.1% | +$509.00M | ||
| 1995 | $3.38B | +13.7% | +$407.00M | ||
| 1994 | $2.98B | +37.2% | +$807.00M | ||
| 1993 | $2.17B | +1.3% | +$27.00M | ||
| 1992 | $2.14B | +27.8% | +$466.00M | ||
| 1991 | $1.68B | +1.1% | +$18.00M | ||
| 1990 | $1.66B | +32.6% | +$407.00M | ||
| 1989 | $1.25B | — | — |
- 2025$24.53B+1.1%
- 2024$24.27B+6.5%
- 2023$22.79B+7.5%
- 2022$21.19B-9.5%
- 2021$23.41B-0.5%
- 2020$23.54B+0.5%
- 2019$23.42B+5.5%
- 2018$22.20B+5.4%
- 2017$21.06B+12.2%
- 2016$18.77B-2.7%
- 2015$19.28B+4.4%
- 2014$18.47B+6.1%
- 2013$17.41B+13.1%
- 2012$15.40B+7.7%
- 2011$14.30B-12.7%
- 2010$16.39B-1.1%
- 2009$16.57B+10.7%
- 2008$14.97B-1.8%
- 2007$15.25B+7.0%
- 2006$14.25B+20.0%
- 2005$11.88B+6.7%
- 2004$11.13B+5.1%
- 2003$10.60B+29.6%
- 2002$8.18B-7.8%
- 2001$8.86B+35.1%
- 2000$6.56B+15.6%
- 1999$5.68B+16.2%
- 1998$4.89B+12.5%
- 1997$4.34B+11.6%
- 1996$3.89B+15.1%
- 1995$3.38B+13.7%
- 1994$2.98B+37.2%
- 1993$2.17B+1.3%
- 1992$2.14B+27.8%
- 1991$1.68B+1.1%
- 1990$1.66B+32.6%
- 1989$1.25B—
Operating Cash Flow values are taken from Johnson & Johnson's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Johnson & Johnson (JNJ)
Operating Cash Flow for Johnson & Johnson (JNJ): headline value $2.51B · YoY +1.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Johnson & Johnson (JNJ) operating cash flow totalled $24.53B – edged up 1.1% year-over-year.
Through 2020–2025 (5 years), Johnson & Johnson operating cash flow delivered a +0.8% annualised rate; sustaining 3 straight years of year-over-year growth.
Across the available history, operating cash flow reached its high of $24.53B in 2025 and its low of $1.25B in 1989.
Johnson & Johnson Operating Cash Flow by Year
Johnson & Johnson Operating Cash Flow 2025: $24.53B
In 2025, Johnson & Johnson reported operating cash flow of $24.53B, edged up 1.1% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Operating Cash Flow 2024: $24.27B
Johnson & Johnson operating cash flow in 2024 was $24.27B, grew 6.5% from 2023.
Johnson & Johnson Operating Cash Flow 2023: $22.79B
2023's operating cash flow for Johnson & Johnson came in at $22.79B, grew 7.5% from 2022.
Johnson & Johnson Operating Cash Flow 2022: $21.19B
Johnson & Johnson posted operating cash flow of $21.19B in 2022, declined 9.5% below 2021.
Johnson & Johnson Operating Cash Flow 2021: $23.41B
Johnson & Johnson operating cash flow in 2021 was $23.41B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Operating Cash Flow
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest operating cash flow
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B | |
| $7.82B |
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation